These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21048432)

  • 21. The analysis of very small samples of repeated measurements I: an adjusted sandwich estimator.
    Skene SS; Kenward MG
    Stat Med; 2010 Nov; 29(27):2825-37. PubMed ID: 20839367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computing for incomplete repeated measures.
    Berk K
    Biometrics; 1987 Jun; 43(2):385-98. PubMed ID: 2440484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeated-measures analysis of variance in developmental research: selected issues.
    Hertzog C; Rovine M
    Child Dev; 1985 Aug; 56(4):787-809. PubMed ID: 4042744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing onset of antidepressant action using a repeated measures approach and a traditional assessment schedule.
    Mallinckrodt CH; Detke MJ; Kaiser CJ; Watkin JG; Molenberghs G; Carroll RJ
    Stat Med; 2006 Jul; 25(14):2384-97. PubMed ID: 16217850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statistical methods for efficiency adjusted real-time PCR quantification.
    Yuan JS; Wang D; Stewart CN
    Biotechnol J; 2008 Jan; 3(1):112-23. PubMed ID: 18074404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Applying linear mixed models to estimate reliability in clinical trial data with repeated measurements.
    Vangeneugden T; Laenen A; Geys H; Renard D; Molenberghs G
    Control Clin Trials; 2004 Feb; 25(1):13-30. PubMed ID: 14980746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Power comparison of summary measure, mixed model, and survival analysis methods for analysis of repeated-measures trials.
    Zucker DM; Manor O; Gubman Y
    J Biopharm Stat; 2012; 22(3):519-34. PubMed ID: 22416838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multilevel models for repeated measures research designs in psychophysiology: an introduction to growth curve modeling.
    Kristjansson SD; Kircher JC; Webb AK
    Psychophysiology; 2007 Sep; 44(5):728-36. PubMed ID: 17596179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time-dependent predictors in clinical research, performance of a novel method.
    van de Bosch J; Atiqi R; Cleophas TJ
    Am J Ther; 2010; 17(6):e202-7. PubMed ID: 20393346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Twice random, once mixed: applying mixed models to simultaneously analyze random effects of language and participants.
    Janssen DP
    Behav Res Methods; 2012 Mar; 44(1):232-47. PubMed ID: 21858733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modelling and estimating heterogeneous variances in threshold models for ordinal discrete data via Winbugs/Openbugs.
    Foulley JL; Jaffrézic F
    Comput Methods Programs Biomed; 2010 Jan; 97(1):19-27. PubMed ID: 19520453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypothesis testing in functional linear regression models with Neyman's truncation and wavelet thresholding for longitudinal data.
    Yang X; Nie K
    Stat Med; 2008 Mar; 27(6):845-63. PubMed ID: 17610294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correct use of repeated measures analysis of variance.
    Park E; Cho M; Ki CS
    Korean J Lab Med; 2009 Feb; 29(1):1-9. PubMed ID: 19262072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statistical power analysis for growth curve models using SAS.
    Zhang Z; Wang L
    Behav Res Methods; 2009 Nov; 41(4):1083-94. PubMed ID: 19897816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An alternative analysis for crossover studies that accounts for between-group disparities in drug response.
    Cleophas TJ
    Int J Clin Pharmacol Ther; 1997 Nov; 35(11):504-8. PubMed ID: 9401831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statistical methods for the analysis of relapse data in MS clinical trials.
    Wang YC; Meyerson L; Tang YQ; Qian N
    J Neurol Sci; 2009 Oct; 285(1-2):206-11. PubMed ID: 19709676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Random-effects models for multivariate repeated measures.
    Fieuws S; Verbeke G; Molenberghs G
    Stat Methods Med Res; 2007 Oct; 16(5):387-97. PubMed ID: 17656450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment.
    Kilian R; Matschinger H; Löeffler W; Roick C; Angermeyer MC
    J Ment Health Policy Econ; 2002 Mar; 5(1):21-31. PubMed ID: 12529567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of two different electronic health record user interfaces on intensive care provider task load, errors of cognition, and performance.
    Ahmed A; Chandra S; Herasevich V; Gajic O; Pickering BW
    Crit Care Med; 2011 Jul; 39(7):1626-34. PubMed ID: 21478739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.